NCBiotech Eyes Center to Capitalize on State's Personalized Medicine Culture | GenomeWeb

NEW YORK (GenomeWeb News) – The North Carolina Biotechnology Center sees the state as a potential hub for personalized medicine research and business, and has provided $100,000 for a project to begin exploring the possibility of creating a center that would focus on commercializing technologies to individualize medical diagnosis and treatment of each patient.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.